Home / News / Research

Research

DM2 Research News

Researchers at the University of Illinois recently re-engineered small molecules to disrupt toxic RNA repeats involved in DM2.

The DMCRN

The DMCRN was established a little over three years ago to evaluate potential DM treatments, prepare possible clinical trial sites and conduct important DM research studies.

Scientific and Clinical Community Provides Valuable Guidance

Dr. Darren Monckton is an internationally-known DM researcher who provides valuable information to the MDF community. Check out his videos and upcoming webinar that will explore the significance of CTG repeats for people with DM and how to understand blood test results.

Ionis Launches Phase 1 Trial of IONIS-DMPK Rx to Treat DM1

Ionis Pharmaceuticals, Inc. (formerly Isis Pharmaceuticals, Inc.) announced today that it has launched a Phase 1 clinical trial for IONIS-DMPKRX. IONIS-DMPKRX is designed to reduce the production of toxic dystrophia myotonic-protein kinase (DMPK) RNA in cells, including muscle cells, for the treatment of Myotonic Dystrophy Type 1 (DM1).

DM2 Patients and Statins

Researchers identify the gene believed to be responsible for adverse statin drug side effects in DM2 patients.  

Stanford University Creates Myotonic Dystrophy Biobank

Stanford University has created the Myotonic Dystrophy Biobank to aid researchers in advancing therapies.

MDF Advances DM Research with Fund-a-Fellow Grants

In early May, the Foundation announced a Request for Applications for this year's MDF Fund-a-Fellow program. The Fund-a-Fellow program supports our commitment to Care and a Cure for myotonic dystrophy by attracting new investigators to the field of DM research, ultimately advancing DM science and the search for treatments.

Stanford University Myotonic Dystrophy Biobank

Stanford University has launched the DM Biobank to provide high-quality DM biological samples to researchers around the world. By participating in the Biobank, DM community members can play an important role in the development of new therapies that may help patients today and for generations to come.

DM Research News

A recently published study from Sweden reported impaired facial recognition in people with DM1 and indicated that there are brain differences that affect how faces are perceived and stored by people with DM1.

MDF Announces FAF Success

SAN FRANCISCO, CA (March 28, 2014): The Myotonic Dystrophy Foundation (MDF) has published the results of its first-ever Fund-a-Fellow Program Assessment measuring the impact of the first five years of its post-doctoral fellowship grant program.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.